Cardiotoxicity, and specifically LV dysfunction, remains the limiting factor for many anti-neoplastic agents. This title summarizes for the heart failure specialist the possible ways that chemotherapeutic agents might cause cardiotoxicity as well as the methods for detecting, treating and preventing cardiotoxicity.